Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Il-1r1 drives leukemogenesis induced by Tet2 loss

Leukemia(2022)10.1038/s41375-022-01665-3Source: DataRank Database

Il-1r1 drives leukemogenesis induced by Tet2 loss is a research paper published in Leukemia (2022). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: hybridTopics (16)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ramesh Kumar ORCID,Santhosh Kumar Pasupuleti ORCID,Kaman So,Chi Zhang ORCID,Reuben Kapur ORCID

Live enrichment

PubMed:35962058 PMC:PMC9522579

U.S. Department of Health & Human Services | National Institutes of Health

Grant: T32 DK007519

U.S. Department of Health & Human Services | National Institutes of Health

Grant: R01 CA173852

U.S. Department of Health & Human Services | National Institutes of Health

Grant: R01 CA134777

U.S. Department of Health & Human Services | National Institutes of Health

Grant: R01 HL146137

U.S. Department of Health & Human Services | National Institutes of Health

Grant: R01 HL140961

National Institutes of Health

Grant: 5U54DK106846-03

Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy

National Institutes of Health

Grant: 5R01HL146137-03

Targeting Novel Pathways in JMML

National Institutes of Health

Grant: 5R01CA173852-10

Role of p21 activated kinase in Leukemogenesis

National Institutes of Health

Grant: 3T32DK007519-18S1

REGULATION OF HEMATOPOIETIC CELL PRODUCTION

National Institutes of Health

Grant: 3P30CA082709-16S3

Indiana University Melvin and Bren Simon Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA134777-08

Role of Shp2 in FLT3-ITD induced leukemogenesis

National Institutes of Health

Grant: 1R01HL140961-01A1

Hyperglycemia mediated myeloproliferative disease

U.S. Department of Health & Human Services | National Institutes of Health

hybridLicense: cc-by

publisherhttps://www.nature.com/articles/s41375-022-01665-3.pdf

publisherhttps://www.nature.com/articles/s41375-022-01665-3

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/38320e98-23fe-47ba-a5d9-4bdf6f39058f/download

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9522579

Europe_PMChttps://europepmc.org/articles/PMC9522579

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

LeukemiaDioxygenasesDNA-Binding ProteinsSignal TransductionReceptors, Interleukin-1 Type ICarcinogenesis

Keywords

DNA-Binding ProteinsReceptors, Interleukin-1 Type ILetterLeukemiaCarcinogenesisSignal transductionDioxygenases